| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $25.4M | -21.0% |
| Cost of Revenue | $15.0M | -21.6% |
| Gross Profit | $10.5M | -20.3% |
| R&D Expense | $549K | +87.7% |
| SG&A Expense | $7.6M | +93.5% |
| Operating Income | -$4.6M | -239.9% |
| Interest Expense | $406K | +166.8% |
| Pre-tax Income | -$5.0M | -261.0% |
| Income Tax | $336K |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $840K | -40.1% |
| Accounts Receivable | $466K | +119.1% |
| Inventory | $6.4M | +19.3% |
| Current Assets | $14.0M | +72.1% |
| Total Assets | $33.7M | +16.3% |
| Current Liabilities | $12.7M | +62.9% |
| Total Liabilities | $23.9M | +7.6% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | -333.5% |
| Capital Expenditures | $1.6M | +30.4% |
| Investing Cash Flow | -$2.9M | +9.4% |
| Financing Cash Flow | $12.5M | — |
| Free Cash Flow | -$11.7M | -482.7% |
| -71.6% |
| Net Income | -$5.3M | -379.2% |
| EPS (Basic) | -$1.10 | -1322.2% |
| Stockholders' Equity |
| $9.8M |
| +45.0% |